Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling

Formulating a therapeutic strategy that can effectively combat concurrent infections of Actinobacillus pleuropneumoniae (A. pleuropneumoniae) and Pasteurella multocida (P. multocida) can be challenging. This study aimed to 1) establish minimum inhibitory concentration (MIC), minimum bactericidal con...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eon-Bee, Abbas, Muhammad Aleem, Park, Jonghyun, Tassew, Dereje D., Park, Seung-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556534/
https://www.ncbi.nlm.nih.gov/pubmed/37808183
http://dx.doi.org/10.3389/fphar.2023.1258403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556534/
https://www.ncbi.nlm.nih.gov/pubmed/37808183
http://dx.doi.org/10.3389/fphar.2023.1258403

Ejemplares similares